Hodgkin's Lymphoma Incidence Rates
In medicine–in this case oncology–the "incidence rate" is the number of new disease cases that will occur in a given population.
According to the Leukemia and Lymphoma Society, Hodgkin's Lymphoma represents about 11% of all lymphoma diagnoses. Approximately 8,000 cases (4,400 males and 3,820 females) of Hodgkin's Lymphoma are detected per year which represents less than 1% of all cancers. Nevertheless, this is a still a significant disease worldwide and incidents are on the rise.
Selected Hodgkin's Incidence Statistics
From The National Cancer Institute's SEER program. Numbers are based on cases diagnosed in 2002-2006 from 17 SEER geographic areas.
Median age at diagnosis: 64 years
3.0% were diagnosed under age 20; 7.5% between 20 and 34; 8.4% between 35 and 44; 13.7% between 45 and 54; 17.8% between 55 and 64; 20.4% between 65 and 74; 21.4% between 75 and 84; and 7.8% 85+ years of age.
Incidence Rates by Race/Gender
Men
- All Races: 26.6 per 100,000 men
- White: 27.7 per 100,000 men
- Black: 21.2 per 100,000 men
- Asian/Pac Islander 17.0 per 100,000 men
- American Indian/Alaska Native: 12.9 per 100,000 men
- Hispanic: 22.0 per 100,000 men
Women
- All Races: 18.9 per 100,000 women
- White: 19.8 per 100,000 women
- Black: 14.5 per 100,000 women
- Asian/Pacific Islander: 12.0 per 100,000 women
- American Indian/Alaska Native 10.7 per 100,000 women
- Hispanic: 16.5 per 100,000 women
More data can be found on the SEER page for Hodgkin's Lymphoma.
Resources
- U.S. Cancer Statistics from the CDC
- Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK (eds). SEER Cancer Statistics Review, 1973-1996, National Cancer Institute. Bethesda, MD, 1999.
- US National Cancer Institute SEER Data - Hodgkin's Lymphoma
- American Cancer Institute - Key Statistics for Hodgkin's Disease
- The (US) Leukemia & Lymphoma Society - Hodgkin Lymphoma
- Cancer Research UK - Statistics and prognosis of Hodgkin's lymphoma
- MedlinePlus - Hodgkin's Disease
Further Reading
- Hodgkin's Lymphoma: Diagnosis
- Hodgkin's Lymphoma: Treatment
- Hodgkin's Lymphoma: Chemotherapy
- Hodgkin's Lymphoma: Resources
More Articles
More Articles
Cutaneous T-Cell Lymphoma (CTCL) is a rare, low grade (indolent) type of...
In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...
Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...
In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.
Why B...
MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...
Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...
T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...
In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...
Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...
After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...
The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...
In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...
Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...
In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...